OTC : HLMAF

Halma plc — News

$48.885 USD

-$0.68 (-1.36%)

Volume
771
Average Volume
11.43K
Market Capitalization
$18.46B
P/E Ratio
36.88
Dividend Yield
0.68%
Price Target
Year High
$66.22
Year Low
$41.77
Day High
Day Low
Payout Ratio
$0.24
Current Ratio
$2.14
Source Headline
Halma (OTCMKTS:HLMAF) Shares Gap Up – Still a Buy?

Halma (OTCMKTS:HLMAF - Get Free Report)'s share price gapped up before the market opened on Friday. The stock had previously closed at $47.5230, but opened at $49.3210. Halma shares last traded at $49.3910, with a volume of 628 shares changing hands. Analysts Set New Price Targets Several equities analysts have commented on HLMAF shares.

defenseworld.net - 2026-07-19 04:02:07

Short Interest in Halma (OTCMKTS:HLMAF) Rises By 81.5%

Halma (OTCMKTS:HLMAF - Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 288,780 shares, a growth of 81.5% from the June 15th total of 159,111 shares. Currently, 0.1% of the company's shares are short sold. Based on an average trading

defenseworld.net - 2026-07-17 04:41:17

Halma continues dealmaking spree with pair of healthcare acquisitions

Halma PLC (LSE:HLMA) has struck a pair of healthcare acquisitions worth a combined £54 million, extending its dealmaking spree after its biggest ever year for acquisitions. The FTSE 100 safety equipment group said it had acquired Dutch hospital software business Itemedical for €23 million (about £20 million), and Sweden's Naslund Medical for $45 million (about £34 million).

proactiveinvestors.co.uk - 2026-07-02 03:00:34

Halma sell-off created an entry point some investors have been waiting for says analyst

Halma PLC's (LSE:HLMA) sharp post-results sell-off has created the “entry point” investors had been waiting for, according to UBS, which reiterated its Buy rating and 4,775p price target on the safety, healthcare and industrial technology group. The Swiss bank said the shares' 15% fall after the company's FY26 results and FY27 guidance looked like “a pure derating” rather than a deterioration in the investment case.

proactiveinvestors.co.uk - 2026-06-15 11:07:59

Halma H2 Earnings Call Highlights

Halma LON: HLMA reported what management described as a “very strong” full-year 2026 performance, with broad-based organic growth across all three of its sectors and continued rapid expansion in its Photonics business.

marketbeat.com - 2026-06-11 05:03:45

British device maker Halma's shares slump on slower annual growth forecast

British health and safety device maker Halma forecast organic constant-currency revenue growth for fiscal ​2027 at a slower rate than the previous ‌year, sending its shares down nearly 15% on Thursday.

reuters.com - 2026-06-11 04:52:37

Halma Shares Drop After Guidance Disappoints

The stock fell to the bottom of the FTSE 100 after the company issued guidance that pointed to a smaller boost from its photonics business.

wsj.com - 2026-06-11 04:13:00

Halma raises dividend less than expected after revenue and profit beat forecasts

Halma PLC (LSE:HLMA) listed its dividend 7% to continue its run of successive hikes to a 47th year, as it posted annual revenues above £2.5 billion and adjusted profit over £500 million for the first time, both beating market expectations. The FTSE 100 provider of safety, environmental and healthcare technologies reported revenue of £2.58 billion in the year to March, up 15% from the previous year and ahead of the £2.56 billion average City forecast.

proactiveinvestors.co.uk - 2026-06-11 02:58:44

Get HLMAF Insider Trade Alerts

HLMAF Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

HLMAF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade